Huntington's: The Right Treatment for a Rare Disease
June 13th 2017Samuel Frank, MD, director of the Huntington's Disease Society America Centers of Excellence at the Beth Israel Deaconness Medical Center, discusses hitting the moving target of Huntington's treatment, and his research on deutetrabenazine for the rare disease.
Read More
Antibodies for Parkinson's, Possible Vaccinations, and the Movement Disorder Society
June 7th 2017Anthony Lang, MD, FRCPC, professor and director of the Division of Neurology at the University of Toronto, discusses the potentially comprehensive care of investigational disease modifying treatment PRX002,
Read More